| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |